Sign Up Today and Learn More About Ona Therapeutics Stock
Invest in or calculate the value of your shares in Ona Therapeutics or other pre-IPO companies through EquityZen's platform.
Ona Therapeutics Stock
Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.
About Ona Therapeutics Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
Ona Therapeutics Press Mentions
Stay in the know about the latest news on Ona Therapeutics
Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug
medcitynews • Jul 07, 2026
Spain: Ona Therapeutics raises US$86.6m Series B to advance First-in-Class ADCs into clinical development
investorsinhealthcare • Jun 09, 2026
Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer
medcitynews • Jun 06, 2026
Ona raises $86.6M series B for ADCs to treat advanced cancers
bioworld • Jun 05, 2026
Ona Therapeutics Raises $86.6M to Advance Cancer ADC Pipeline
ventureburn • Jun 05, 2026
Ona Therapeutics Management
Leadership team at Ona Therapeutics
Board Member
Jean-François Morin
Co-founder and Chief Executive Officer
Valerie Vanhooren
Join now and verify your accreditation status to gain access to:
- Ona Therapeutics Current Valuation
- Ona Therapeutics Stock Price
- Ona Therapeutics Management
- Available deals in Ona Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ona Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Ona Therapeutics Revenue and Financials
- Ona Therapeutics Highlights
- Ona Therapeutics Business Model
- Ona Therapeutics Risk Factors
- Ona Therapeutics Research Report from SACRA Research
Trading Ona Therapeutics Stock
How to invest in Ona Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Ona Therapeutics through EquityZen funds. These investments are made available by existing Ona Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Ona Therapeutics stock?
Shareholders can sell their Ona Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."